Amid an ongoing court review of its $69 billion merger with health insurer Aetna, CVS Health isn’t slowing down in its plans to expand, according to executives who spoke at the company’s investor day on June 4.

Medivis, a New York-based healthcare technology company, announced that its new augmented reality (AR) surgical platform has received FDA approval.

Implementing a same-day biopsy program can help providers address ongoing disparities in patient care, according to a new study published in the Journal of the American College of Radiology.

Prompted by a New York Times deep-dive into elevated death rates at North Carolina Children’s Hospital, North Carolina’s secretary of health on May 31 called for an investigation into the hospital’s pediatric heart surgery unit.

Brand-name drugs are likely to keep rising in price, even though the top-selling ones have been available for years and have already seen their costs skyrocket, according to a new study published in JAMA.

Tempus, a Chicago-based precision medicine company that uses machine learning, genomic sequencing and other AI innovations, has raised $200 million in a series F funding round, the company announced.

The U.S. Nuclear Regulatory Commission (NRC) is considering changing training and experience requirements for administering radiopharmaceuticals that require a written directive.

CVS Health is gearing up to defend its $69 billion takeover of the nation’s third-largest health insurer, Aetna, The Wall Street Journal reported.